US Supreme Court backs ‘rule-of-reason’ for pay-for-delay
17-06-2013
OFT accuses GSK of market abuse over pay-for-delay deals
19-04-2013
The European Commission’s competition directorate has levied fines totalling €146 million ($195 million) against originator pharmaceutical company Lundbeck and several producers of generics drugs.
If you have already subscribed please login.
If you have any technical issues please email tech support.
Lundbeck, EPO, European Commission, citalopram
